[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][C][N][=C][Branch1][Ring2][N][Ring1][Branch1][N][C][=C][Branch1][=N][C][=N][C][=C][N][=C][Ring1][=Branch1][C][=C][Ring1][#Branch2][Br]"}, {"from": "gpt", "value": "The molecule is only found in individuals that have used or taken this drug. It is a drug used to treat glaucoma. It acts via decreasing aqueous humor synthesis. [Wikipedia] A topical gel formulation, marketed under the name Mirvaso, was FDA approved on August 2013 for the treatment of rosacea. Brimonidine is an alpha adrenergic receptor agonist (primarily alpha-2). It has a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that Brimonidine has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow."}]